Prognostic Value of Pulse Oximetry Differences
Prognostic Significance of Multi-site Pulse Oximetry Differences in Dyspneic Emergency Department Patients
調査の概要
状態
条件
詳細な説明
This is a prospective observational cohort study conducted in a single ED to evaluate the prognostic significance of inter-site differences in pulse oximetry in adult patients presenting with dyspnea.
Adult patients (≥19 years) presenting with dyspnea and classified as Korean Triage and Acuity Scale (KTAS) levels 1-3 will be enrolled at the time of ED admission. During initial vital sign assessment at ED presentation, SpO₂ will be simultaneously measured at the finger, earlobe, and forehead, along with the corresponding perfusion index at each site.
The primary exposure of interest is the difference between finger and earlobe SpO₂ (ΔSpO₂). Additional inter-site SpO₂ differences involving forehead measurements will also be evaluated. Clinical and physiological data at presentation will be collected prospectively, while outcome data will be obtained through retrospective medical record review.
The primary outcome is the mean difference in ΔSpO₂ between patients with poor outcomes-defined as all-cause mortality from ED admission to hospital discharge or intensive care unit (ICU) admission-and those with favorable outcomes. Secondary outcomes include the associations of ΔSpO₂ with mortality, ICU admission, endotracheal intubation, serum lactate levels, and perfusion index, as well as the predictive performance of ΔSpO₂ using logistic regression and receiver operating characteristic (ROC) analysis. The prognostic value of ΔSpO₂ will also be compared with established early warning scores such as NEWS.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Stephen GW LEE, MD
- 電話番号:82-10-5124-8415
- メール:leestephengyungwon@yuhs.ac
研究場所
-
-
Seoul
-
Seoul、Seoul、韓国、03722
- 募集
- Yonsei University Severance Hospital
-
コンタクト:
- Stephen GW LEE, MD
- 電話番号:82-2-2228-2678
- メール:LEESTEPHENGYUNGWON@YUHS.AC
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Adult patients aged 19 years or older presenting to the emergency department with dyspnea, classified as KTAS level 1-3
Exclusion Criteria:
- Patients in whom SpO₂ measurements were not obtained simultaneously
- Patients in whom arterial blood gas analysis was not ordered at initial evaluation
- Pregnant patients
- Patients with facial trauma or hand trauma
- Patients with amputation, injury, or burns at the measurement sites
- Patients wearing nail polish
- Patients with dyshemoglobinemia
- Non-Korean nationality
- Patients who did not provide consent to participate in the study
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
|---|
|
Dyspnea cohort
Patients visiting emergency department with dyspnea who are categorized to KTAS 1-3
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
In-hospital mortality or ICU admission
時間枠:From the index emergency department visit through hospital discharge, assessed up to 6 months.
|
In-hospital mortality or ICU admission of index visit
|
From the index emergency department visit through hospital discharge, assessed up to 6 months.
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 4-2025-1489
- 6-2025-0076 (その他の助成金/資金番号:Yonsei University College of Medicine)
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。